CN Patent

CN105906621A — 用作fgfr抑制剂的乙醇类化合物

Assigned to Sichuan Baili Pharmaceutical Co Ltd · Expires 2016-08-31 · 10y expired

What this patent protects

本发明公开了一种用作FGFR抑制剂的乙醇类化合物。本发明提供了式I化合物或其在药学上可接受的盐，还提供了制备式I化合物的方法，和式I化合物作为药物和在癌症治疗中的用途。

USPTO Abstract

本发明公开了一种用作FGFR抑制剂的乙醇类化合物。本发明提供了式I化合物或其在药学上可接受的盐，还提供了制备式I化合物的方法，和式I化合物作为药物和在癌症治疗中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105906621A
Jurisdiction
CN
Classification
—
Expires
2016-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Baili Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.